September 13, 2024 (Washington, DC) The Partnership to Fight Chronic Disease (PFCD) released the following statement upon delivery of a sign on letter to Congress from more than 30 patient and consumer advocacy groups calling for support of the bipartisan Ensuring Pathways to Innovative Cures (EPIC
SAN DIEGO, CA – On September 4th, the Partnership to Fight Chronic Disease (PFCD) will host an event in collaboration with California State Assemblymember Dr. Akilah Weber, focusing on the physical and mental health needs of Black women as they navigate the postpartum period. The event will
IRA’s “negotiated” prices represent much #MoreThanAList when considering access impacts and lack of savings for millions of chronic disease patients
August 15, 2024 (WASHINGTON, DC) The Partnership to Fight Chronic Disease (PFCD) today released the following statement in
Case studies highlight peril to treatment advances across several disease states
August 14, 2024 (WASHINGTON, DC) The Partnership to Fight Chronic Disease (PFCD) today announced the release of a new data set that highlights critical risks posed to the development and delivery of new
Ensuring access and coverage remains a top priority
July 3, 2024 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) released the following statement in response to the U.S. Food and Drug Administration (FDA) traditional approval of KisunlaTM (donanemab), a therapy developed
By Hannah Pfeiffer and Candace DeMatteis
June 5, 2024
Boulder Daily Camera
A group of unelected state officials is pondering a decision with enormous consequences for thousands of Colorado patients battling chronic diseases.
In 2021, Colorado established a Prescription Drug
May 1, 2024
The impact of the Inflation Reduction Act on the price of medicine is starting to play out. Measures to cap the price of insulin at $35 a month for Medicare enrollees took effect on Jan. 1.
In 2025, the IRA will cap annual out-of-pocket prescription drug costs
April 2, 2024 (Washington, DC) Today the Partnership to Fight Chronic Disease (PFCD) released a new white paper, “Health Plans Predict: Implementing Upper Payment Limits May Alter Formularies and Benefit Design But Won’t Reduce Patient Costs,” which details feedback from
Unintended consequences for chronic disease patients are many
March 8, 2024 (WASHINGTON, D.C.) The Partnership to Fight Chronic Disease (PFCD) today released the following statement from Chair Ken Thorpe in response to President Biden’s State of the Union address:
“
By Ken Thorpe
February 22, 2024
Law360
In December, the White House issued a new policy framework that could have devastating effects on access to cutting-edge drugs. The proposal would radically reinterpret a 43-year-old law to let the government march in and take patents